Cargando…
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Ustekinumab has shown efficacy in Crohn’s Disease (CD) patients. To identify patient profiles of those who benefit the most from this treatment would help to position this drug in the therapeutic paradigm of CD and generate hypotheses for future trials. The objective of this analysis was to determin...
Ejemplares similares
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
por: Chaparro, María, et al.
Publicado: (2022) -
Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19
por: Núñez-Torrón, Claudia, et al.
Publicado: (2020) -
COVID-19 pandemic, as experienced in the surgical service of a district hospital in Spain
por: Pérez Lara, Francisco Javier, et al.
Publicado: (2021) -
Human 3D Pose Estimation with a Tilting Camera for Social Mobile Robot Interaction
por: Garcia-Salguero, Mercedes, et al.
Publicado: (2019) -
Hereditary Coproporphyria Associated with the Q306X Mutation in the Coproporphyrin Oxidase Gene Presenting with Acute Ataxia
por: Jiménez-Jiménez, Félix Javier, et al.
Publicado: (2013)